Liquid Meal Replacements in Conjunction With Lifestyle Intervention in Overweight Adolescents
Overweight, Obesity

About this trial
This is an interventional treatment trial for Overweight focused on measuring overweight, obesity, adolescent
Eligibility Criteria
Inclusion Criteria: BMI >85th% for age and sex Weight gain over the last 6 months of >5% than expected on the growth curve 12-17 years of age Exclusion Criteria: Subjects with intolerance to dairy products (e.g., lactose intolerance) will be excluded from entering into the study. Subjects must not have a history of clinically significant cardiac disease, congenital heart disease, any clinically significant abnormal cardiac condition, or be known to have a clinically significantly abnormal ECG. Specifically excluded conditions include coronary artery disease, clinically significant cardiac arrhythmias, and congestive heart failure. Subjects must not have a history of anorexia nervosa, untreated hypothyroidism (TSH greater than 4.0 mU/L for a second generation test), malignancy, pathophysiologic or genetic syndromes associated with obesity (i.e., Cushing's syndrome, Turner's syndrome, Prader Willi syndrome), major psychiatric illness such as bi-polar disorder, ADD, major depression, bulimia, schizophrenia, or psychosis. Subjects may not participate in any weight management program, except for that in this study, during this pilot. Subjects may not use prescription or over-the-counter (or herbal) weight control medication during the trial. Subjects must not have a history of alcohol or drug addiction or substance abuse within the previous 2 years.
Sites / Locations
- Boston University Medical